From AI-powered insurance bots to drug discovery platforms, these overlooked stocks offer pure-play exposure to artificial intelligence without trillion-dollar valuations.
But the fate of the AI trade increasingly hinges on just one company, according to a Wall Street veteran, who sees possible ...